We review treatment options related to myopia control including the new FDA approved lenses MiSight 1-Day by CooperVision, and share upcoming research in this area from Keyur Savla, BOptom and Celia Gong, OD.

Resources:

1. Review of Optometry Article on Myopia Treatments: https://www.reviewofoptometry.com/article/myopia-treatments-how-to-choose-and-when-to-use

2. Yam JC, Jiang Y, Tang SM, et al. Low-concentration atropine for myopia progression (LAMP) study. Ophthalmology 2019; 126(1): 113-124.

3. Collaborative Eye Article on Myopia Control and New Developments: https://collaborativeeye.com/articles/nov-dec-19/myopia-a-global-epidemic/

4. CHAPERONE Study: https://clinicaltrials.gov/ct2/show/NCT03942419

5. CHAMP study: https://clinicaltrials.gov/ct2/show/NCT03350620 (USA)

6. Wu PW, Chen CT, Chang LC, et al. Increased time outdoors is followed by reversal of the long-term trend to reduce visual acuity in Taiwan primary school students. Ophthalmology 2020; doi:https://doi.org/10.1016/j.ophtha.2020.01.054

7. Myopia Control Calculator: https://bhvi.org/myopia-calculator-resources/myopia-news/